# Vinorelbine in Mesothelioma

> **NCT02139904** · PHASE2 · COMPLETED · sponsor: **Wales Cancer Trials Unit** · enrollment: 154 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **DRUG:** Vinorelbine
- **OTHER:** Active Symptom Control

## Key facts

- **NCT ID:** NCT02139904
- **Lead sponsor:** Wales Cancer Trials Unit
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2021-03-17
- **Final completion:** 2021-03-17
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2021-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139904, "Vinorelbine in Mesothelioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02139904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*